Impact of school nurse education on factors influencing HPV vaccine communication with parents Authors: Jihye Choi, Efrat K. Gabay, Jeanette Deason, Elizabeth Baumler, Diane Santa Maria, Daisy Mullassery, Lara S. Savas, Erika Thompson, Sanghamitra M. Misra, Paula M. Cuccaro Published: 2026 ABSTRACT ABSTRACTHuman papillomavirus (HPV) can cause six cancer types but can be prevented with timely vaccination in early adolescence. However, despite the wide availability of the HPV vaccine, uptake remains suboptimal among US adolescents. School nurses are invaluable resources to students and their families regarding adolescent immunization needs. As part of the All for Them vaccination program, we assessed the impact of the continued nurse education (CNE) intervention on school nurses’ HPV vaccine communication with parents. Seventy-two school nurses and nurse administrators in Texas participated in the study. Using a single-arm study design, we measured participants’ potential barriers to and self-efficacy for recommending the HPV vaccine, and knowledge about HPV and the vaccine. Data were collected between November 2021 and May 2023. We evaluated differences in survey responses using paired t-test and McNemar-Bowker chi-square test. Participants’ uncertainty about HPV vaccine efficacy was significantly reduced at follow-up (P < .001). More participants indicated that their HPV knowledge (P = .003) and understanding of the recommended dosing schedule for the vaccine (P = .003) were not barriers at all at follow-up. Participants’ confidence to communicate with parents about HPV vaccination significantly increased across six self-efficacy variables at follow-up (P < .001). The CNE intervention appeared to improve nurses’ HPV and HPV vaccine-related knowledge and increased their self-efficacy to communicate about HPV vaccination with parents, while lessening their perceived barriers to do so. The CNE can be a key resource to support school nurses’ professional practice, facilitating their high-quality HPV vaccine recommendations to adolescents and parents. Introduction Human papillomavirus (HPV) infection is highly prevalent and responsible for the development of six cancers but can be prevented, or significantly reduced, with on-time vaccination in early adolescence. Although the Advisory Committee on Immunization Practices (ACIP) and CDC have recommended the HPV vaccine for nearly two decades, vaccine uptake remains suboptimal among adolescents in the United States (US) as most states do not require HPV vaccination for school-entry.1 In 2022, 76% of US adolescents aged 13–17 y had received ≥1 HPV vaccine doses and 63% were up to date with the HPV vaccine series.2 In Texas, 58.5% of adolescents aged 13–17 y had completed the vaccine series in 2022.3 Racial/ethnic minority adolescents from rural and medically underserved areas face amplified challenges receiving the vaccine and are at disproportionately higher risk for HPV and HPV-associated cancers in adulthood.4 Youth typically have fewer visits to healthcare providers during their transition from childhood to adolescence, which leads to missed opportunities for timely vaccination among older adolescents.5 As a liaison between healthcare and the community, school nurses are invaluable resources to students and their families with regards to adolescent immunization needs, especially in low socioeconomic areas.6,7 However, school nurses may lack knowledge about CDC-recommended vaccines not required for school entry, including the HPV vaccine.8 They may also perceive themselves as less knowledgeable or comfortable in communicating with parents about such vaccines.9 Tailored education for school nurses can help increase their knowledge and confidence to recommend due or overdue HPV vaccination.10 To increase HPV vaccine uptake among Texas youth in medically underserved areas, the multilevel, multicomponent All for Them vaccination program was implemented in school districts varying in geographic region, size, and population. All for Them comprises three synergistic theory- and evidence-based strategies: 1) a parent-focused social marketing campaign to increase HPV vaccine awareness; 2) comprehensive school-based vaccination clinics; and 3) continuing nurse education (CNE) for school nurses in participating school districts and statewide. We framed this study applying Social Cognitive Theory to specify participating school nurses’ individual determinants (e.g., knowledge, self-efficacy) that can be improved following the uptake of the intervention. Social Cognitive Theory has been widely used to guide the development and evaluation of educational behavioral interventions targeting changes in knowledge, attitudes, self-efficacy, and related preventive health practices among healthcare professionals and patients.11 This study focuses on understanding the impact of online CNE for school nurses across Texas. The 90-minute CNE course was developed based on continuing education for clinic-based healthcare providers previously developed within the team’s research center12 and subsequently modified and expanded to include components that helped nurses champion HPV vaccination in their schools. The CNE aimed to 1) increase HPV and HPV vaccine knowledge; 2) promote positive vaccine attitudes; 3) offer effective strategies to provide a strong recommendation for and communicate about HPV vaccination with parents; and 4) deliver skills training to record HPV vaccination in school immunization records. To understand the impact of the CNE, we assessed pre- and post-intervention changes in factors influencing school nurses’ HPV vaccine recommendations and communication with parents, including knowledge, attitudes, self-efficacy, and intentions. Methods Study design We used a single-arm study design to draw a convenience sample of school nurses pre- and post-intervention to evaluate changes in nurses’ knowledge, barriers to recommendation, self-efficacy for communication with parents, vaccine attitudes, and intentions to change practice following the CNE intervention. The UTHealth Houston Committee for the Protection of Human Subjects provided ethical oversight and approval for this study (HSC-SPH-20–0356). All participants provided informed consent before commencing each survey. We adhered to STROBE reporting guidelines (File 1). Participants and data collection School nurses were recruited through our research center’s newsletters, Texas School Nurses Organization’s newsletters, Texas Pediatric Society listserv, school district health services leaders, presentations shared on project and collaborator social media channels, and word of mouth. The baseline survey started in November 2021, and participants were invited to complete the follow-up survey 1 month after completing the intervention (i.e., CNE course) with multiple reminders in the weeks following the invitation. The average time between baseline surveys and course completion was 9.3 d. The average time between course completion and follow-up surveys was 146.6 d. The follow-up surveys ended in May 2023, with an average of 95 d between baseline and follow-up survey administration. The CNE intervention The online asynchronous CNE was offered free to all school nurses and school health staff serving all grade levels in school districts across Texas. The following topics were covered in the CNE: 1) HPV and HPV-associated cancers, 2) HPV vaccine, immunization schedule, and its importance, 3) the critical role school nurses play in recommending HPV vaccination, 4) effective strategies for HPV vaccination communication with parents, 5) steps for becoming an HPV champion, 6) experiences of HPV-related cancer and infection survivors, 7) experiences of other Texas school nurses in communication with parents about HPV vaccination, and 8) skills for entering HPV and other recommended vaccines into district immunization records. The CNE consistently emphasized the importance of implementing best practices to improve HPV vaccination rates in schools, including bundling the HPV vaccine with other required adolescent vaccines and framing HPV vaccination as cancer prevention. Measures We collected nurses’ background characteristics, including age, gender, race/ethnicity, years working as a school nurse or nurse administrator, and grade levels they served. Participants were asked to select a preferred age range to vaccinate their child against HPV. Eight items assessed potential barriers to recommending HPV vaccination and were measured with response options of “not a barrier at all,” “somewhat a barrier” and “major barrier.” Eight items assessed participants’ self-efficacy to communicate with parents and recommend HPV vaccination. Items were measured on a 4-point Likert scale with responses ranging from strongly disagree to strongly agree. We measured participants’ HPV and HPV vaccine-related knowledge using “true,” “false,” and “do not know” response options. Participants that responded to an item correctly were coded as correct, incorrect responses and responses of “don’t know” were coded as incorrect. In the follow-up survey, participants were asked about their anticipated use of skills learned in the CNE. These items were adapted from the research team’s previous work on physician perceptions of HPV vaccination initiation and increasing HPV vaccination in pediatric clinics.12 For this study, we presented item-level analyses. Data analysis We presented responses descriptively for the paired sample at baseline (pre-intervention) and follow-up (post-intervention). Within-person change was evaluated using paired t-test for the knowledge outcomes and McNemar-Bowker chi-square test for all other categorial outcomes. When assumptions for the McNemar–Bowker test were not satisfied, such as the case of zero categories, the Wilcoxon Rank Sum test was used. Type I error for all tests was set at 0.05. The maximum missing value for any given analysis was one case, therefore we conducted a complete case analysis. Results The sample comprised 72 school nurses and nurse administrators from 24 counties in Texas. Table 1 provides a profile of the study sample. Nearly all participants were female (98.6%), predominantly non-Hispanic White (69.4%), and between the ages of 35 and 55 (61.1%). Participants reported having worked as nurses in schools for approximately 8 y on average. Over half of the participants served pre-K to 5th grade and 6th to 8th grades, although these groups of grades were not mutually exclusive.Table 1.Demographic and school characteristics of nurse participants (N = 72).CharacteristicFrequency (%)Age 20–3416 (22.2) 35–4426 (36.1) 45–5418 (25.0) 55+12 (16.7)Gender Female71 (98.6) Male1 (1.4)Race/ethnicity Hispanic13 (18.1) Non-Hispanic Black4 (5.6) Non-Hispanic White50 (69.4) Asian1 (1.4) Other/prefer not to answer4 (5.6)Years as a school nurse or nurse administrator Mean (SD)8.17 (9.1)Grade levels serveda Pre-K − 5th40 (55.6) 6th − 8th38 (52.8) 9th − 12th30 (41.7)aNot mutually exclusive. Table 1.Demographic and school characteristics of nurse participants (N = 72).CharacteristicFrequency (%)Age 20–3416 (22.2) 35–4426 (36.1) 45–5418 (25.0) 55+12 (16.7)Gender Female71 (98.6) Male1 (1.4)Race/ethnicity Hispanic13 (18.1) Non-Hispanic Black4 (5.6) Non-Hispanic White50 (69.4) Asian1 (1.4) Other/prefer not to answer4 (5.6)Years as a school nurse or nurse administrator Mean (SD)8.17 (9.1)Grade levels serveda Pre-K − 5th40 (55.6) 6th − 8th38 (52.8) 9th − 12th30 (41.7)aNot mutually exclusive. Demographic and school characteristics of nurse participants (N = 72). aNot mutually exclusive. We found that most participants with children in the recommended age range for HPV vaccination preferred to vaccinate their children against HPV at 11–12 y of age both before and after the CNE intervention (66.1% baseline and 58.5% follow-up, respectively). The greatest change in vaccination age preference occurred in the 9–10 age group (5.4% baseline vs. 20.8% follow-up). Although there were no statistically significant differences, fewer participants selected older age groups (11–12, 13–14, and 15–18 y) as preferred ages to vaccinate their own children following the intervention. Most participants provided correct answers on all the knowledge items prior to the CNE intervention (Table 2). For example, almost all participants (97.2%) knew accurately about male susceptibility to HPV and the possibility of asymptomatic HPV transmission. Participants were significantly more likely to correctly answer the items at follow-up: HPV transmission through genital skin-to-skin contact (83.3% vs 93.1%, P = .03), most sexually active people will get HPV at some point in their lives (62.5% vs 84.7%, P < .001), the vaccine works best when given at a younger age (72.2% vs 93.1%, P < .001).Table 2.Nurse self-reported HPV and HPV vaccine knowledge: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Knowledge Item (n = 72)aPre-Interventionn (%) CorrectPost-Interventionn (%) CorrectChangeHPV can be transmitted through genital skin-to-skin contact. (True)60 (83.3%)67 (93.1%)9.8%*Men cannot get infected with HPV. (False)70 (97.2%)71 (98.6%)1.4%Most sexually active people will get HPV at some point in their lives. (True)45 (62.5%)61 (84.7%)22.2%**HPV can be transmitted even when an infected person has no signs or symptoms. (True)70 (97.2%)71 (98.6%)1.4%The vaccine works best when given at a younger age. (True)52 (72.2%)67 (93.1%)20.9%***P < .05, **P < .001 from paired t-test.aOne participant missing for all items at follow-up. Table 2.Nurse self-reported HPV and HPV vaccine knowledge: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Knowledge Item (n = 72)aPre-Interventionn (%) CorrectPost-Interventionn (%) CorrectChangeHPV can be transmitted through genital skin-to-skin contact. (True)60 (83.3%)67 (93.1%)9.8%*Men cannot get infected with HPV. (False)70 (97.2%)71 (98.6%)1.4%Most sexually active people will get HPV at some point in their lives. (True)45 (62.5%)61 (84.7%)22.2%**HPV can be transmitted even when an infected person has no signs or symptoms. (True)70 (97.2%)71 (98.6%)1.4%The vaccine works best when given at a younger age. (True)52 (72.2%)67 (93.1%)20.9%***P < .05, **P < .001 from paired t-test.aOne participant missing for all items at follow-up. Nurse self-reported HPV and HPV vaccine knowledge: Baseline (pre-intervention) and follow-up (post-intervention) surveys. *P < .05, **P < .001 from paired t-test. aOne participant missing for all items at follow-up. Participants reported increased knowledge of HPV vaccination cancer prevention post intervention. Significantly more participants knew that HPV vaccination can prevent anal (54.2% vs 84.7%), oropharyngeal (50.0% vs 86.1%), penile (50.0% vs 84.7%), vaginal (59.7% vs 86.1%), and vulvar cancers (54.2% vs 86.1%), and oral/laryngeal papillomas (44.4% vs 70.8%). All pre-post changes were statistically significant (P < .001). Table 3 shows the participants’ rating of perceived barriers to recommending HPV vaccination to students and parents. Prior to the CNE intervention, top barriers to recommending the vaccine were 1) HPV vaccine is not required for school attendance; and 2) concern about parents’ negative perceptions about the HPV vaccine. Both before and after the intervention, vaccine safety and efficacy concerns were not barriers for the majority of participants. Post intervention, fewer participants indicated that concern about parents’ negative HPV vaccine perceptions was a major barrier and more participants indicated that personal discomfort talking about sexuality with students and/or parents was not a barrier at all. However, these changes were not statistically significant. Even after the intervention, the time it takes to discuss HPV vaccination with students and parents and the HPV vaccine not being required for school attendance remained major barriers for most participants. Concern about parents’ negative vaccine perceptions was also considered somewhat of a barrier (61.4%) or a major barrier (9.7%) for over half of the participants post-intervention. The change from baseline to follow-up responses for these outcomes, however, was not statistically significant. Significant positive changes were observed post intervention for barriers around the level of knowledge about HPV (P = .003), moving from 48.6% indicating this was not a barrier to 75.0%. Understanding of the recommended dosing schedule for the HPV vaccine significantly improved (P = .003), with participants reporting a reduction in the number identifying this as not a barrier from baseline to follow-up (52.8% vs 77.8%).Table 3.Nurse self-reported barriers to recommending HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Nurse Barriers Item (n = 72)Pre-Interventionn (%)Post-Interventionn (%)p-valueLevel of knowledge about HPV .003a Not a Barrier35 (48.6%)54 (75.0%) Somewhat of a Barrier29 (40.3%)16 (22.2%) Major Barrier8 (11.1%)2 (2.8%) Concern about parents’ negative perceptions about the HPV vaccine .06a Not a Barrier19 (26.4%)21 (29.2%) Somewhat of a Barrier35 (48.6%)44 (61.1%) Major Barrier18 (25.0%)7 (9.7%) Personal discomfort talking about sexuality with students and/or parents .23a Not a Barrier44 (61.1%)51 (70.8%) Somewhat of a Barrier25 (34.7%)18 (25.0%) Major Barrier3 (4.2%)3 (4.2%) Concern about vaccine safety .32b Not a Barrier60 (83.3%)65 (90.3%) Somewhat of a Barrier12 (16.7%)6 (8.3%) Major Barrier0 (0%)1 (1.4%) Concern about vaccine efficacy .41b Not a Barrier59 (81.9%)64 (88.9%) Somewhat of a Barrier12 (16.7%)7 (9.7%) Major Barrier0 (0%)1 (1.4%) The HPV vaccine is not required for school attendance .29a Not a Barrier20 (27.8%)12 (16.7%) Somewhat of a Barrier32 (44.4%)38 (52.8%) Major Barrier19 (26.4%)22 (30.6%) The time it takes to discuss HPV vaccination with students and parents .05a Not a Barrier20 (27.8%)28 (38.9%) Somewhat of a Barrier32 (44.4%)33 (45.8%) Major Barrier19 (26.4%)11 (15.3%) Understanding of the recommended dosing schedule for the HPV vaccine .003a Not a Barrier38 (52.8%)56 (77.8%) Somewhat of a Barrier29 (40.3%)14 (19.4%) Major Barrier5 (6.9%)2 (2.8%) aMcNemar-Bowker.bWilcoxon Signed Rank. Table 3.Nurse self-reported barriers to recommending HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Nurse Barriers Item (n = 72)Pre-Interventionn (%)Post-Interventionn (%)p-valueLevel of knowledge about HPV .003a Not a Barrier35 (48.6%)54 (75.0%) Somewhat of a Barrier29 (40.3%)16 (22.2%) Major Barrier8 (11.1%)2 (2.8%) Concern about parents’ negative perceptions about the HPV vaccine .06a Not a Barrier19 (26.4%)21 (29.2%) Somewhat of a Barrier35 (48.6%)44 (61.1%) Major Barrier18 (25.0%)7 (9.7%) Personal discomfort talking about sexuality with students and/or parents .23a Not a Barrier44 (61.1%)51 (70.8%) Somewhat of a Barrier25 (34.7%)18 (25.0%) Major Barrier3 (4.2%)3 (4.2%) Concern about vaccine safety .32b Not a Barrier60 (83.3%)65 (90.3%) Somewhat of a Barrier12 (16.7%)6 (8.3%) Major Barrier0 (0%)1 (1.4%) Concern about vaccine efficacy .41b Not a Barrier59 (81.9%)64 (88.9%) Somewhat of a Barrier12 (16.7%)7 (9.7%) Major Barrier0 (0%)1 (1.4%) The HPV vaccine is not required for school attendance .29a Not a Barrier20 (27.8%)12 (16.7%) Somewhat of a Barrier32 (44.4%)38 (52.8%) Major Barrier19 (26.4%)22 (30.6%) The time it takes to discuss HPV vaccination with students and parents .05a Not a Barrier20 (27.8%)28 (38.9%) Somewhat of a Barrier32 (44.4%)33 (45.8%) Major Barrier19 (26.4%)11 (15.3%) Understanding of the recommended dosing schedule for the HPV vaccine .003a Not a Barrier38 (52.8%)56 (77.8%) Somewhat of a Barrier29 (40.3%)14 (19.4%) Major Barrier5 (6.9%)2 (2.8%) aMcNemar-Bowker.bWilcoxon Signed Rank. Nurse self-reported barriers to recommending HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys. aMcNemar-Bowker. bWilcoxon Signed Rank. Table 4 presents the degree to which the participants agreed with having confidence to communicate with parents about HPV vaccination. Before the CNE intervention, participants were already confident in their ability to explain the benefits of HPV vaccination to parents, shown by the highest combined percentages of somewhat agree and strongly agree responses (77.8%). Few participants strongly agreed that they were confident to influence parents’ decision about whether to get the HPV vaccine for their child and convince hesitant parents to get the vaccine. However, there were significant post-intervention increases in the participants’ confidence to communicate with parents about HPV vaccination across all six self-efficacy variables (P < .001). More than half of the participants somewhat agreed with being confident to influence parents’ HPV vaccine decision (58.3%) and convince hesitant parents to get the vaccine (55.6%). More participants also strongly agreed with being confident to address specific parental concerns about the vaccine and age 11–12 vaccination post-intervention. Above all, there was a considerable rise in the percentage of strongly agree responses regarding confidence to explain HPV vaccine benefits to parents (22.2% baseline vs. 58.3% follow-up) and to provide a strong HPV vaccine recommendation to parents (23.6% baseline vs. 55.6% follow-up).Table 4.Self-efficacy to communicate with parents about HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Nurse Self-Efficacy Communication Item (n = 72)Pre-Interventionn (%)Post-Interventionn (%)p-valueI am able to influence parents’ decision about whether to get the HPV vaccine for their child <.001a Strongly disagree14 (19.4%)3 (4.2%) Somewhat disagree27 (37.5%)24 (33.3%) Somewhat agree29 (40.3%)42 (58.3%) Strongly agree2 (2.8%)3 (4.2%) I am usually able to convince hesitant parents to get the HPV vaccine <.001a Strongly disagree17 (23.6%)7 (9.7%) Somewhat disagree35 (48.6%)24 (33.3%) Somewhat agree18 (25.0%)40 (55.6%) Strongly agree2 (2.8%)1(1.4%) I am confident that I can address specific parental concerns about the HPV vaccine (e.g., safety, effectiveness, sexual activity) <.001b Strongly disagree8 (11.1%)0 (0%) Somewhat disagree17 (23.6%)4 (5.6%) Somewhat agree37 (51.4%)39 (54.2%) Strongly agree10 (13.9%)29 (40.3%) I am confident that I can address parental concerns about vaccinating their child at age 11 or 12 <.001b Strongly disagree4 (5.6%)0 (0%) Somewhat disagree20 (27.8%)3 (4.2%) Somewhat agree38 (52.8%)40 (55.6%) Strongly agree10 (13.9%)29 (40.3%) I am confident that I can explain the benefits of HPV vaccination to parents <.001b Strongly disagree2 (2.8%)0 (0%) Somewhat disagree14 (19.4%)2 (2.8%) Somewhat agree40 (55.6%)28 (38.9%) Strongly agree16 (22.2%)42 (58.3%) I am confident that I can provide a strong recommendation for HPV vaccination to parents <.001b Strongly disagree3 (4.2%)0 (0%) Somewhat disagree19 (26.4%)5 (6.9%) Somewhat agree33 (45.8%)27 (37.5%) Strongly agree17 (23.6%)40 (55.6%) aMcNemar-Bowker.bWilcoxon Signed Rank. Table 4.Self-efficacy to communicate with parents about HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys.Nurse Self-Efficacy Communication Item (n = 72)Pre-Interventionn (%)Post-Interventionn (%)p-valueI am able to influence parents’ decision about whether to get the HPV vaccine for their child <.001a Strongly disagree14 (19.4%)3 (4.2%) Somewhat disagree27 (37.5%)24 (33.3%) Somewhat agree29 (40.3%)42 (58.3%) Strongly agree2 (2.8%)3 (4.2%) I am usually able to convince hesitant parents to get the HPV vaccine <.001a Strongly disagree17 (23.6%)7 (9.7%) Somewhat disagree35 (48.6%)24 (33.3%) Somewhat agree18 (25.0%)40 (55.6%) Strongly agree2 (2.8%)1(1.4%) I am confident that I can address specific parental concerns about the HPV vaccine (e.g., safety, effectiveness, sexual activity) <.001b Strongly disagree8 (11.1%)0 (0%) Somewhat disagree17 (23.6%)4 (5.6%) Somewhat agree37 (51.4%)39 (54.2%) Strongly agree10 (13.9%)29 (40.3%) I am confident that I can address parental concerns about vaccinating their child at age 11 or 12 <.001b Strongly disagree4 (5.6%)0 (0%) Somewhat disagree20 (27.8%)3 (4.2%) Somewhat agree38 (52.8%)40 (55.6%) Strongly agree10 (13.9%)29 (40.3%) I am confident that I can explain the benefits of HPV vaccination to parents <.001b Strongly disagree2 (2.8%)0 (0%) Somewhat disagree14 (19.4%)2 (2.8%) Somewhat agree40 (55.6%)28 (38.9%) Strongly agree16 (22.2%)42 (58.3%) I am confident that I can provide a strong recommendation for HPV vaccination to parents <.001b Strongly disagree3 (4.2%)0 (0%) Somewhat disagree19 (26.4%)5 (6.9%) Somewhat agree33 (45.8%)27 (37.5%) Strongly agree17 (23.6%)40 (55.6%) aMcNemar-Bowker.bWilcoxon Signed Rank. Self-efficacy to communicate with parents about HPV vaccination: Baseline (pre-intervention) and follow-up (post-intervention) surveys. aMcNemar-Bowker. bWilcoxon Signed Rank. Changes in the participants’ responses regarding asking parents about reasons for vaccine refusal were not significant. However, the shifts trended in the desired direction, with a reduction in the strongly disagree response (16.7% baseline to 6.9% follow-up) and an increase in the strongly agree response (12.5% baseline to 20.8% follow-up). In the follow-up survey, the majority of participants (95.8%) reported that they intended to use the skills they learned in the CNE. The most common ways in which they would use the learned skills were as follows: “communicate more with parents about HPV vaccine” (76.8%), “increase parent education” (63.8%), “encourage early vaccination” (58.0%) and “strongly recommend HPV vaccination for students” (58.0%). One nurse indicated already using practices as outlined in the training, and one indicated not serving students in the eligible age groups for HPV vaccination. Discussion This study examined the impact of the CNE intervention on school nurses’ HPV vaccine-related knowledge, beliefs, and communication using a single arm pre-post matched pair sample. In addition to resolving uncertainty and providing clarification about the HPV vaccine, the CNE intervention brought change in nurses’ perceptions about the vaccine and its administration at younger ages. The intervention also helped alleviate most nurses’ current perceived barriers to recommending the vaccine while significantly improving their confidence to communicate with parents about HPV vaccination. It was not surprising that experienced nurses in this study already had adequate knowledge about HPV and the HPV vaccine at baseline. However, their knowledge may have been limited to cervical cancer prevention, and some gaps may exist that necessitate tailored education for nurses in general.13 For example, nurses tend to be less familiar with the actual prevalence of HPV infection, HPV vaccine specifics, and the effectiveness of the vaccine in preventing six HPV-related cancers affecting males and females, including cervical cancer.14,15 While several nurses in this study were initially uncertain about the high likelihood of HPV infection among sexually active people and increased efficacy of earlier HPV vaccination, their uncertainty was significantly reduced after the CNE intervention. This finding aligns with their increased selection of age 9–10 vaccination, which is supported by a previous study’s intervention impact on informing school nurses that preteens are the best population to prioritize for vaccination.16 Additionally, significantly more nurses recognized vaccine effectiveness against all noncervical HPV-associated cancers post-intervention. Such recognition can foster nurses to frame HPV vaccination as cancer prevention17 and attenuate the overidentification of the vaccine with sexual activity. It is critical that school nurses have up-to-date HPV-related knowledge to disseminate to parents and guide decision-making. Nurses should remember that parental vaccine hesitancy does not equal outright refusal but instead arises from lack of knowledge and involves various degrees of indecision.18 When speaking with parents, nurses’ focus should be on diseases attributable to HPV rather than vaccine side effects, given the interest in the benefit to the child, especially for cancer prevention.19 This is a likely precursor to their self-efficacy to engage parents and students in the HPV vaccine discussion.20,21 Despite initially lower perceived importance for the HPV vaccine compared to other school-required adolescent immunizations, more than half of the nurses perceived its importance after the CNE intervention. This shift suggests intervention effectiveness and warrants continuation of HPV vaccination-related advocacy work for school nurses. In the broader context of adolescent immunizations, healthcare providers tend to endorse the HPV vaccine less strongly than Tdap or MCV4 vaccines and often discuss it last.22 School nurses, who have the salient role of linking the medical and school communities, may also be inadvertently reluctant to promote the HPV vaccine due to having lower perceived vaccine importance.23 In our study, more nurses indicated that the HPV vaccine not being required for school attendance was a major barrier. Vaccine mistrust plays a bigger role for non-mandated vaccines;24 therefore, requiring the vaccine for school entry may substantially increase its perceived importance by nurses. Tailored education to heighten awareness of HPV vaccine importance to the same extent as required immunizations can help nurses become key opinion leaders regarding adolescent HPV vaccination.25 Subsequently, higher adolescent HPV vaccination rates can be achieved. We also confirmed nurses’ increased preference to vaccinate their own child at age 9–10 post-intervention and that their preference generally shifted to younger ages. Nurses’ acceptance of early HPV vaccination for their own children may facilitate the way in which they make vaccine recommendations to parents who show ambivalence toward the vaccine. Sharing professionally credible nurses’ personal HPV vaccine decisions can appeal to parents at different stages of readiness to vaccinate their children. Indeed, a recent study noted that physicians most cited having their own children receive the HPV vaccine as a first-line strategy for addressing parental hesitancy.26 Nurses’ current barriers to making HPV vaccine recommendations appeared to be alleviated after the CNE intervention but the effect was limited to their personal barriers. For example, nurses indicated their own understanding and knowledge of the HPV vaccine as barriers to a lesser extent post-intervention. Several other barriers persisted even after the intervention. Concern about parents’ negative reactions remained somewhat of a barrier for most of the nurses, parallel with findings from previous research of school nurses and their perspective on school-based HPV vaccine promotion.27 Additionally, nurses still anticipated that nurse-student and nurse–parent interactions were challenging to overcome. More nurses indicated that the time it takes to discuss HPV vaccination was a major barrier in addition to the vaccine not being required for school attendance. The latter obstacle may be fundamentally due to the absence of an HPV vaccine school-entry requirement in Texas and may be addressed through state policy changes.28 Despite its complexity, expanding the adolescent vaccine school-entry requirement to include the HPV vaccine series is feasible as successfully demonstrated by Rhode Island, Virginia, and Washington, D.C.1,29 School-entry HPV vaccine requirements could allay parents’ hesitancy and reduce nurses’ burden of approaching the topic of HPV vaccination. Moreover, it would improve provider comfort in making a strong, presumptive vaccine recommendation and consequently increase vaccine coverage, especially for some socioeconomic and racial/ethnic groups.30 This synergistic effect may help resolve inequity in HPV vaccination and ensure reduction in health disparities associated with HPV-related diseases in medically underserved populations.31 The CNE intervention was potentially effective in improving nurses’ confidence about recommending HPV vaccination, as observed by statistically significant increases on six self-efficacy variables and intention to leverage the skills learned in the CNE to communicate more with parents and increase parent education. Contrary to nurses’ initially high level of disagreement, there was a positive shift to somewhat agreement with being confident to influence parents’ HPV vaccine decisions, convince hesitant parents, and address parental concerns about the vaccine. While this effect may not appear to be greatly compelling, it is also not negligible. It may be premature to expect from one educational intervention a drastic growth in nurses’ confidence to recommend the HPV vaccine to parents. A previous study of school nurses from Missouri described that despite moderate HPV-related knowledge, many disagreed it was important for them to influence parental decisions.25 Some reservation may still exist for nurses to lead HPV vaccine communication if there is immense parental reluctance or if nurses think the complexity of their position in the school is not well understood by parents.32 Nurses in this study were generally optimistic about the HPV vaccine. While they were already somewhat confident in explaining benefits of the vaccine even before the CNE intervention, there was a considerable post-intervention rise in the number of nurses with strong confidence to do so and strongly recommend the vaccine to parents. These results align with HPV vaccine safety and efficacy concerns not being barriers for nurses when making vaccine recommendations as well as their improved vaccine knowledge post-intervention. Notably, these results together suggest that the nurses have obtained accurate information about the HPV vaccine, as well as recommendation-making skills, which can bolster their confidence for vaccine communication. To that end, a recent review of vaccine communication interventions concluded that focusing on the weight of scientific consensus about vaccines and warning against overt disinformation were promising strategies to counter vaccine misinformation and dispel related myths.33 This study has several limitations. The primary limitation is the use of a one group pre-post design. Without a randomized study design with a control condition, we cannot definitively attribute our findings to the intervention. While the results are promising, findings should be viewed as a preliminary assessment of intervention effectiveness. There was a lack of consistency in the time of baseline and follow-up survey administration. Although the follow-up survey was planned to take place one month after the intervention, nurses took an average of 146.6 d between the baseline and follow-up surveys. The wider than anticipated window of follow-up may impact a subject’s recall ability. While changes in outcomes of knowledge, barriers to communication, and self-efficacy are hypothesized to endure, the variation in follow-up time leaves open the likelihood that other temporal variations outside of intervention exposure could impact the study outcomes. Additionally, the measures for this study are self-reported. This method of data collection may be open to social desirability bias or other forms of misclassification. Finally, the small size of the matched sample is not sufficiently powered to detect small differences and limits the reliability and generalizability of our study to a broader population. The small sample size yields limited representation as well as an increased potential for self-selection bias due to the recruitment protocol. Nurses with a more favorable view toward the HPV vaccine may be more likely to participate in the study. While the results from the study are promising, further research is needed to assess the effectiveness of the intervention. As we continue to implement the All for Them program, we expect additional school nurses to participate, providing us with the opportunity to conduct a more robust analysis of intervention effectiveness. Effective vaccine communication and knowledge dissemination are critical to allay concerns of vaccine-hesitant parents because adolescent vaccination is contingent on parental decisions. As a trusted source of vaccine information, school nurses are in an important position for HPV vaccine promotion. Following the completion of the online CNE intervention, nurses’ knowledge about HPV and the HPV vaccine improved and perceived barriers to recommend the vaccine decreased while their self-efficacy to communicate with parents about HPV vaccination increased. Nurses’ intention to provide high-quality HPV vaccine recommendations also increased after the intervention, urging timely vaccination and ultimately protecting adolescents from HPV-associated cancers. Supplementary Material STROBE checklist.docx